Eco-friendly Biosynthesis of Ag-NPs by Streptomyces griseus with Anti-Candida albicans and Antitumor Activity

Author:

Abou El-Enain Inas M.1,Abed Nermine N.1,Helal Eman E.2,Abdelkhalek Eman S.1,Suleiman Waleed3,Safwat Nesreen A.4,Yosri Mohammed4

Affiliation:

1. Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City, Cairo 11841, Egypt

2. Department of Microbiology International Islamic Center for Population Studies and Research, Al-Azhar University, Al-Darrassa Ward, 11651, Cairo, Egypt

3. Department of Microbiology, Faculty of Science, Al Azhar University, Nasr City, 11841, Cairo, Egypt

4. The Regional Center for Mycology and Biotechnology, Al-Azhar University, 11787, Nasr City, Cairo, Egypt

Abstract

Background: The most significant sexually transmissible fungal disease, semen candidiasis, is caused by Candida albicans and impacts male reproductive potential. Actinomycetes are a group of microorganisms that could be isolated from various habitats and used for the biosynthesis of various nanoparticles with biomedical applications. Objective: Testing antifungal activity of biosynthesized Ag nanoparticles versus isolated C. albicans from semen as well as its anticancer activity versus the Caco-2 cell line. Methods: Screening 17 isolated actinomycetes for the biosynthesis of Ag nanoparticle biosynthesis. Characterization of biosynthesized nanoparticles, testing its anti-Candida albicans, and antitumor activity. Results: Streptomyces griseus was the isolate that identified silver nanoparticles using UV, FTIR, XRD and TEM. Biosynthesized nanoparticles have promising anti-Candida albicans with MIC (125 ± 0.8) μg/ml and accelerate apoptotic rate versus Caco-2 cells (IC50 = 7.30 ± 0.54 μg/ml) with minimal toxicity (CC50 = 142.74 ± 4.71 μg/ml) versus Vero cells. Conclusion: Certain actinomycetes could be used for the biosynthesis of nanoparticles with successive antifungal and anticancer activity to be verified by in vivo studies.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3